Table 3.
Objective evaluation at 1st week (p = 0.307)
| Sac syringing | With stent (group A) | Without stent (group B) |
|---|---|---|
| Fully patent | 19 | 22 |
| Partly patent | 4 | 3 |
| Blocked | 2 | 0 |
Objective evaluation at 1st week (p = 0.307)
| Sac syringing | With stent (group A) | Without stent (group B) |
|---|---|---|
| Fully patent | 19 | 22 |
| Partly patent | 4 | 3 |
| Blocked | 2 | 0 |